Canlyniadau Chwilio - Lakshmi Nayak
- Dangos 1 - 20 canlyniadau o 36
- Ewch i'r Dudalen Nesaf
-
1
-
2
Glioblastoma in the elderly gan Fábio M. Iwamoto, Anna R. Cooper, Anne S. Reiner, Lakshmi Nayak, Lauren E. Abrey
Cyhoeddwyd 2009Artigo -
3
-
4
-
5
-
6
-
7
High‐dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first com... gan Zachariah DeFilipp, Shuli Li, Areej El‐Jawahri, Philippe Armand, Lakshmi Nayak, Nancy Wang, Tracy T. Batchelor, Yi‐Bin Chen
Cyhoeddwyd 2017Artigo -
8
-
9
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma gan Lakshmi Nayak, Fábio M. Iwamoto, Ann S. LaCasce, Srinivasan Mukundan, Margaretha G.M. Roemer, Bjoern Chapuy, Philippe Armand, Scott J. Rodig, Margaret A. Shipp
Cyhoeddwyd 2017Artigo -
10
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma gan Lakshmi Nayak, Lauren E. Abrey, Jan Drappatz, Mark R. Gilbert, David A. Reardon, Patrick Y. Wen, Michael D. Prados, Lisa M. DeAngelis, Antonio Omuro
Cyhoeddwyd 2012Artigo -
11
-
12
Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative gan Linda Dirven, Terri S. Armstrong, Jaishri O. Blakeley, Paul D. Brown, Robin Grant, Rakesh Jalali, Heather Leeper, Tito R. Mendoza, Lakshmi Nayak, Jaap C. Reijneveld, Émilie Le Rhun, Tobias Walbert, Michael Weller, Patrick Y. Wen, Martin Klein
Cyhoeddwyd 2018Revisão -
13
The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab gan Raymond Y. Huang, Rifaquat Rahman, Karla V. Ballman, Sara J. Felten, S. Keith Anderson, Benjamin M. Ellingson, Lakshmi Nayak, Eudocia Q. Lee, Lauren E. Abrey, Evanthia Galanis, David A. Reardon, Whitney B. Pope, Timothy F. Cloughesy, Patrick Y. Wen
Cyhoeddwyd 2015Artigo -
14
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma gan Matthew J. Frigault, Jörg Dietrich, Maria Martinez‐Lage, Mark B. Leick, Bryan D. Choi, Zachariah DeFilipp, Yi‐Bin Chen, Jeremy S. Abramson, Jennifer L. Crombie, Philippe Armand, Lakshmi Nayak, Chris Panzini, Lauren S. Riley, Kathleen Gallagher, Marcela V. Maus
Cyhoeddwyd 2019Artigo -
15
Extent of resection and overall survival for patients with atypical and malignant meningioma gan Ayal A. Aizer, Wenya Linda Bi, Manjinder Singh Kandola, Eudocia Q. Lee, Lakshmi Nayak, Mikael L. Rinne, Andrew D. Norden, Rameen Beroukhim, David A. Reardon, Patrick Y. Wen, Ossama Al‐Mefty, Nils D. Arvold, Ian F. Dunn, Brian M. Alexander
Cyhoeddwyd 2015Artigo -
16
Central nervous system involvement by Waldenström macroglobulinaemia (Bing‐Neel syndrome): a multi‐institutional retrospective study gan Jorge J. Castillo, Shirley D’Sa, Michael P. Lunn, Monique C. Minnema, Alessandra Tedeschi, Frederick Lansigan, M. Lia Palomba, Marzia Varettoni, Ramón García‐Sánz, Lakshmi Nayak, Eudocia Q. Lee, Mikael L. Rinne, Andrew D. Norden, Irene M. Ghobrial, Steven P. Treon
Cyhoeddwyd 2015Artigo -
17
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study gan Jorge J. Castillo, Gilad Itchaki, Jonas Paludo, Marzia Varettoni, Christian Buske, Toby A. Eyre, Julio C. Chávez, Kenneth H. Shain, Samar Issa, M. Lia Palomba, Oren Pasvolsky, David Simpson, Dipti Talaulikar, Constantine S. Tam, Alessandra Tedeschi, Stephen M. Ansell, Lakshmi Nayak, Steven P. Treon
Cyhoeddwyd 2018Artigo -
18
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101 gan Tracy T. Batchelor, Sharmila Giri, Amy S. Ruppert, Susan M. Geyer, Scott E. Smith, Nimish Mohile, Lode J. Swinnen, Jonathan W. Friedberg, Brad S. Kahl, Nancy L. Bartlett, Eric D. Hsi, Bruce D. Cheson, Nina D. Wagner‐Johnston, Lakshmi Nayak, John P. Leonard, James L. Rubenstein
Cyhoeddwyd 2024Artigo -
19
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study gan Nicholas Butowski, Howard Colman, John de Groot, Antonio Omuro, Lakshmi Nayak, Patrick Y. Wen, Timothy F. Cloughesy, Adhirai Marimuthu, Sam Haidar, Arie Perry, Jason T. Huse, Joanna J. Phillips, Brian L. West, K. B. Nolop, Henry H. Hsu, Keith L. Ligon, Annette M. Molinaro, Michael D. Prados
Cyhoeddwyd 2015Artigo -
20
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older gan Jacob G. Scott, Luc Bauchet, Tyler J. Fraum, Lakshmi Nayak, Anna R. Cooper, Samuel T. Chao, John H. Suh, Michael A. Vogelbaum, David M. Peereboom, Sonia Zouaoui, Hélène Mathieu‐Daudé, Pascale Fabbro‐Peray, Valérie Rigau, Luc Taillandier, Lauren E. Abrey, Lisa M. DeAngelis, Joanna H. Shih, Fábio M. Iwamoto
Cyhoeddwyd 2012Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Internal medicine
Medicine
Oncology
Surgery
Cancer
Cancer research
Chemotherapy
Clinical trial
Lymphoma
Immunotherapy
Primary central nervous system lymphoma
Biology
Cohort
Confidence interval
Immunology
Glioma
Immune system
Proportional hazards model
Radiation therapy
Radiology
Bevacizumab
Central nervous system
Environmental health
Glioblastoma
Hazard ratio
Medical physics
Meningioma
Pathology
Population
Receptor